advertising
-
1
Wild S, Roglic G, Green A, et al: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. .Diabetes Care 27::1047. ,2004. .
-
2
Bild DE, Selby JV, Sinnock P, et al: Lower-extremity amputation in people with diabetes: epidemiology and prevention. .Diabetes Care 12::24. ,1989. .
-
3
Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. .Diabetes Care 13::513. ,1990. .
-
4
Gupta AK, Konnikov N, MacDonald P, et al: Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicenter survey. .Br J Dermatol 139::665. ,1998. .
-
5
Dogra S, Kumar B, Bhansali A, et al: Epidemiology of onychomycosis in patients with diabetes mellitus in India. .Int J Dermatol 41::647. ,2002. .
-
6
Saunte DM, Holgersen JB, Haedersdal M, et al: Prevalence of toenail onychomycosis in diabetic patients. .Acta Derm Venereol 86::425. ,2006. .
-
7
Rich P, Hare A: Onychomycosis in a special patient population: focus on the diabetic. .Int J dermatol 38: (suppl 2) :17. ,1999. .
-
8
Fletcher CL, Hay RJ, Smeeton NC: Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. .Br J Dermatol 148::558. ,2003. .
-
9
Ghannoum MA, Hajjeh RA, Scher R, et al: A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. .J Am Acad Dermatol 43::641. ,2000. .
-
10
Alberhasky RC: Laboratory diagnosis of onychomycosis. .Clin Podiatr Med Surg 21::565. ,2004. .
-
11
Sigurgeirsson B, Steingrimsson O: Risk factors associated with onychomycosis. .J Eur Acad Dermatol Venereol 18::48. ,2004. .
-
12
Gupta AK, Konnikov N, Lynde CW, et al: Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents. .Eur J Dermatol 9::633. ,1999. .
-
13
Lugo-Somolinos A, Sanchez JL: Prevalence of dermatophytosis in patients with diabetes. .J Am Acad Dermatol 26::408. ,1992. .
-
14
Evans SL, Nixon BP, Lee I, et al: The prevalence and nature of podiatric problems in elderly diabetic patients. .J Am Geriatr Soc 39::241. ,1991. .
-
15
Kardjeva V, Summerbell R, Kantardjiev T, et al: Forty-eight-hour diagnosis of onychomycosis with subtyping of Trichophyton rubrum strains. .J Clin Microbiol 44::1419. ,2006. .
-
16
Mahoney JM, Bennet J, Olsen B: The diagnosis of onychomycosis. .Dermatol Clin 21::463. ,2003. .
-
17
Doyle JJ, Boyko WL, Ryu S, et al: Onychomycosis among diabetic patients: prevalence and impact of non-fungal foot infections. Poster presented at: American Diabetes Association 60th Scientific Sessions; June 9–13. ,2000. ; San Antonio, TX.
-
18
Boyko EJ, Ahroni JH, Cohen V, et al: Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. .Diabetes Care 29::1202. ,2006. .
-
19
Weinberg JM, Koestenblatt EK, Tutrone WD, et al: Comparison of diagnostic methods in the evaluation of onychomycosis. .J Am Acad Dermatol 49::193. ,2003. .
-
20
Elewski BE, Leyden J, Rinaldi MG, et al: Office practice-based confirmation of onychomycosis: a US nationwide prospective survey. .Arch Intern Med 162::2133. ,2002. .
-
21
Baek SC, Chae HJ, Houh D, et al: Detection and differentiation of causative fungi of onychomycosis using PCR amplification and restriction enzyme analysis. .Int J Dermatol 37::682. ,1998. .
-
22
Feuilhade de Chauvin M: New diagnostic techniques. .J Eur Acad Dermatol Venereol 19: (suppl 1):20. ,2005. .
-
23
Binstock JM: Molecular biology techniques for identifying dermatophytes and their possible use in diagnosing onychomycosis in human toenail: a review. .JAPMA 97::134. ,2007. .
Diagnosis and Prevalence of Onychomycosis in Diabetic Neuropathic Patients
An Observational Study
Search for other papers by Isabelle J. Dumont in
Current site
Google Scholar
PubMed
Background: An observational study was conducted to assess the prevalence of onychomycosis in clinically suspected diabetic neuropathic patients and to assess the reliability of the diagnosis.
Methods: One hundred successive type 1 and 2 diabetic patients with diabetic neuropathy were followed. Diabetic neuropathy was defined by a vibration perception threshold greater than 25 V and onychomycosis by clinical diagnosis. Samples of the most affected nail were taken. Potassium hydroxide testing and culture were performed. Photographs of the nails were used by two dermatologists for diagnosis.
Results: The mean ± SE age was 62.3 ± 11.4 years for the 20 onychomycotic patients and 60.3 ± 10.4 years for the entire cohort; 14 onychomycotic patients (70%) were male versus 56 in the full cohort (56%) (P < .05). The prevalence of onychomycosis was 20% (culture and potassium hydroxide test positive) and 24% (culture positive). Twenty or 30 patients were positive by the potassium hydroxide test, depending on the investigator. The most frequent pathogen found was Trichophyton rubrum (11 of 20 patients; 55%). The positive predictive values of the dermatologist’s diagnoses were 57.8% and 35.6%, and the negative predictive values were 85.0% and 90.5%. The two expert’s results were significantly different (P < .05).
Conclusions: The diagnosis of onychomycosis is difficult to make. The diagnostic methods commonly used are not satisfactory. If onychomycosis is dangerous for the diabetic foot, a better diagnostic method is needed. (J Am Podiatr Med Assoc 99(2): 135–139, 2009)
advertising
advertising
